Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Quest Diagnostics Incorporated
  6. Summary
    DGX   US74834L1008

QUEST DIAGNOSTICS INCORPORATED

(DGX)
  Report
Delayed Nyse  -  04:03:42 2023-02-03 pm EST
142.81 USD   -1.83%
02/03Wells Fargo Adjusts Quest Diagnostics' Price Target to $140 From $135, Maintains Equal Weight Rating
MT
02/02Transcript : Quest Diagnostics Incorporated, Q4 2022 Earnings Call, Feb 02, 2023
CI
02/02Quest Diagnostics' Q4 Adjusted Earnings, Revenue Fall; Raises Quarterly Dividend
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/30/2023 01/31/2023 02/01/2023 02/02/2023 02/03/2023 Date
145.76(c) 148.48(c) 148.64(c) 145.47(c) 142.81(c) Last
719 609 1 136 008 1 520 052 3 043 014 1 316 045 Volume
+0.09% +1.87% +0.11% -2.13% -1.83% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 9 828 M - -
Net income 2022 1 054 M - -
Net Debt 2022 3 133 M - -
P/E ratio 2022 16,3x
Yield 2022 1,80%
Sales 2023 8 979 M - -
Net income 2023 875 M - -
Net Debt 2023 3 388 M - -
P/E ratio 2023 18,9x
Yield 2023 1,90%
Capitalization 16 264 M 16 264 M -
EV / Sales 2022 1,97x
EV / Sales 2023 2,19x
Nbr of Employees 50 000
Free-Float 67,9%
More Financials
Company
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%). 
Read more
More about the company
Ratings of Quest Diagnostics Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about QUEST DIAGNOSTICS INCORPORATED
02/03Wells Fargo Adjusts Quest Diagnostics' Price Target to $140 From $135, Maintains Equal ..
MT
02/02Transcript : Quest Diagnostics Incorporated, Q4 2022 Earnings Call, Feb 02, 2..
CI
02/02Quest Diagnostics' Q4 Adjusted Earnings, Revenue Fall; Raises Quarterly Dividend
MT
02/02Quest Diagnostics : Q4 Earnings Snapshot
AQ
02/02GUIDANCE: (DGX) QUEST DIAGNOSTICS Expects Fiscal Year 2023 Revenue Range $8.83B..
MT
02/02GUIDANCE: (DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2023 EPS Range $8.40 - $9.00
MT
02/02Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q4 Revenue $2.33B, vs. Street Est of $2.26..
MT
02/02Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q4 EPS $1.98, vs. Street Est of $1.90
MT
02/02Quest Diagnostics Inc : Results of Operations and Financial Condition, Other Events, Finan..
AQ
02/02Quest Diagnostics Incorporated Provides Earnings Guidance for the Full Year of 2023
CI
02/02Tranche Update on Quest Diagnostics Incorporated (N..
CI
02/02Quest diagnostics reports fourth quarter and full year 2022 financial results; provides..
PR
02/02Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion In..
PR
02/02Quest Diagnostics Incorporated Increases Dividend, Payable on April 24, 2023
CI
02/02Quest Diagnostics Incorporated announces an Increase in Equity Buyback
CI
More news
News in other languages on QUEST DIAGNOSTICS INCORPORATED
02/02Le bénéfice ajusté et le chiffre d'affaires du quatrième trimestre de Quest Diagnostics..
02/02Quest Diagnostics Incorporated fournit des prévisions de bénéfices pour l'année complèt..
02/02Quest Diagnostics Incorporated augmente son dividende, payable le 24 avril 2023
02/02Quest Diagnostics Incorporated annonce une augmentation du rachat d'actions
01/17Pack Health, filiale de Quest Diagnostics, va presque doubler l'espace de son siège soc..
More news
Analyst Recommendations on QUEST DIAGNOSTICS INCORPORATED
More recommendations
ETFs positioned on QUEST DIAGNOSTICS INCORPORATEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
AGFiQ US Market Neutral Anti-Beta Fund - USD20.22%-4.42%United_States
ETFMG Treatments Testing and Advancements E...6.37%-0.10%-NC
ASYMshares ASYMmetric 500 ETF - USD6.13%-0.73%-NC
First Trust AlphaDEX U.S. Health Care Secto...2.17%1.74%-United_States
First Trust AlphaDEX U.S. Health Care Secto...2.05%1.96%United_States
More ETFs positioned on QUEST DIAGNOSTICS INCORPORATED
Chart QUEST DIAGNOSTICS INCORPORATED
Duration : Period :
Quest Diagnostics Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 142,81 $
Average target price 149,21 $
Spread / Average Target 4,48%
EPS Revisions
Managers and Directors
James E. Davis President, Chief Executive Officer & Director
Sam A. Samad Chief Financial Officer & Executive Vice President
Stephen H. Rusckowski Executive Chairman
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
QUEST DIAGNOSTICS INCORPORATED-8.71%16 264
CVS HEALTH CORPORATION-7.52%112 699
HCA HEALTHCARE, INC.7.55%72 964
LABORATORY CORPORATION OF AMERICA HOLDINGS8.29%22 092
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY8.88%21 658
FRESENIUS MEDICAL CARE AG & CO. KGAA16.49%14 003